ARTICLE SUMMARY:
Michael John, who is leading MCRA’s new Cardio division, speaks out on the latest trends and challenges in the cardiovascular device arena, including the outlook for transcatheter valve devices; the current paclitaxel controversy in the periphery; and the potential impact of wearable, remote CV monitoring technologies.
MCRA LLC is a contract research organization (CRO) and consulting firm that provides services to the medical device and biologics industries in the areas of clinical research, US and International regulatory, healthcare compliance, quality, and reimbursement. The company is owned by Viscogliosi Brothers LLC (VB), a highly successful family office/private equity firm that invests in the neuro-musculoskeletal/orthopedics/spine arena.
